Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an international clinical trial network at the forefront of diabetes research, today announced a new collaboration agreement to evaluate Nektar's ...
Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
Citizens Medical Center Cardiologist Dr. Kurtis Kreuger won’t sugar coat it. Because of its direct correlation to heart ...
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
1d
HealthDay on MSNProbability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2Diabetes mellitus type 1 (DM1) is associated with lower probability of incident cardiovascular events than type 2 (DM ...
The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.
8hOpinion
The Kenya Times on MSNUnderstanding Diabetes: Can It be Reversed? Who Can Get It? Is there a Special Diet for Those Who Have it?Understanding how to effectively live with diabetes and manage it to maintain a normal life is paramount for anyone affected ...
Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.
Idiopathic pulmonary fibrosis (IPF) and diabetes mellitus do not appear to have a causal association, according to study findings published in Thorax.
Purpose: The pathophysiology, diagnosis, complications, and management of gestational diabetes mellitus (GDM) are discussed, along with considerations in setting up a pharmacist-run GDM education ...
Genetic diabetes risk worsens glycaemic control in stroke patients, impacting recovery and treatment outcomes.
TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results